{"schema_version":"alpha-profile-public-v1","slug":"renee-p-tannenbaum-pharm-d","canonical_url":"https://registry.alpha.ac/people/renee-p-tannenbaum-pharm-d","as_of":"2026-09-22T01:53:10.007546+00:00","published_at":"2026-09-02T02:37:22.434232+00:00","last_reviewed_at":"2026-05-15T23:01:35.659+00:00","identity":{"display_name":"Renee P. Tannenbaum, Pharm.D.","headshot_url":null,"headshot_media":null,"profile_kind":"director","role_tags":["director","executive"],"current_role":{"company_name":"ANI PHARMACEUTICALS INC","company_slug":"ani-pharmaceuticals-inc","exchange":"NASDAQ","ticker":"ANIP","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2022-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1023024/000102302426000039/anip-20260408.htm","effective_date":"2026-04-09","last_checked_at":"2026-04-24T15:55:00.566+00:00"}},"photo_match":null},"assurance":{"is_claimed":false,"status":"unverified","assurance_level":null,"method":null,"verified_at":null,"expires_at":null},"claiming":{"eligible":true,"label":"Is this you? Claim your Alpha Profile","claim_url":"https://terminal.alpha.ac/claim-profile?person=renee-p-tannenbaum-pharm-d","suggest_edit_label":"Suggest an edit","suggest_edit_url":"https://terminal.alpha.ac/claim-profile?person=renee-p-tannenbaum-pharm-d&mode=suggest","canonical_record_will_be_reused":true,"canonical_facts_owner_controlled":false},"presentation":{"schema_version":"alpha-profile-presentation-v1","state":"alpha_editorial","version":0,"published_at":null,"headline":null,"headline_evidence":null,"location":null,"photo":null,"cover":null,"about":["Board director and independent consultant to biopharmaceutical, diagnostic and device companies. Former VP of Global Partnering at Halozyme Therapeutics and Head of Global Customer Excellence at AbbVie. Executive VP and Chief Commercial Officer at Elan Pharmaceuticals. Extensive leadership experience at Novartis, Bristol Myers Squibb and Merck."],"links":[],"sources":[],"featured":[],"competencies":[],"board_preferences":null,"board_service":[{"organization":"ANI PHARMACEUTICALS INC","organizationId":"ani-pharmaceuticals-inc","title":"Director","period":"2022-01-01 · current","evidenceLabel":"sec_proxy","evidenceState":"verified","sourceUrl":"https://www.sec.gov/Archives/edgar/data/1023024/000102302426000039/anip-20260408.htm"},{"organization":"Cardiff Oncology, Inc.","organizationId":"cardiff-oncology-inc","title":"Director","period":"2021-01-01 · current","evidenceLabel":"sec_proxy","evidenceState":"verified","sourceUrl":"https://www.sec.gov/Archives/edgar/data/1213037/000121303726000006/crdf-20260423.htm"}],"experience":[],"education":[],"credentials":[],"section_order":null,"hidden_sections":[],"limitations":["Presentation fields do not alter independently verified Alpha Profile facts.","Owner-supplied résumé records retain their field-level evidence state.","Only confirmed company_person_roles with public evidence. Website governed_site_fallback rows are not invented. about/links are stored people.profile_summary/bio and linkedin_url only. Dates stay undisclosed when the role has no start_date. SoFi Bank is not SoFi Technologies."]},"presentation_authority":"confirmed_company_person_roles","roles":[{"company_name":"ANI PHARMACEUTICALS INC","company_slug":"ani-pharmaceuticals-inc","exchange":"NASDAQ","ticker":"ANIP","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2022-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1023024/000102302426000039/anip-20260408.htm","effective_date":"2026-04-09","last_checked_at":"2026-04-24T15:55:00.566+00:00"}},{"company_name":"Cardiff Oncology, Inc.","company_slug":"cardiff-oncology-inc","exchange":"NASDAQ","ticker":"CRDF","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2021-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1213037/000121303726000006/crdf-20260423.htm","effective_date":"2026-04-23","last_checked_at":"2026-04-24T23:19:01.21+00:00"}}],"claims":[{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Proxy extraction classified AI/ML experience for Renee P. Tannenbaum, Pharm.D. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T23:01:35.828972+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"CRDF DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1213037/000121303726000006/crdf-20260423.htm","published_at":"2026-04-23T00:00:00+00:00","last_checked_at":"2026-05-15T23:01:35.718861+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_role","claim_value":"Director","claim_text":"Renee P. Tannenbaum, Pharm.D. currently serves as Director at Cardiff Oncology, Inc..","claim_state":"verified","valid_from":"2026-04-23","valid_to":null,"confidence":0.92,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T23:01:35.79301+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"CRDF DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1213037/000121303726000006/crdf-20260423.htm","published_at":"2026-04-23T00:00:00+00:00","last_checked_at":"2026-05-15T23:01:35.718861+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_role","claim_value":"Director","claim_text":"Renee P. Tannenbaum, Pharm.D. currently serves as Director at ANI PHARMACEUTICALS INC.","claim_state":"verified","valid_from":"2026-04-09","valid_to":null,"confidence":0.92,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T21:06:10.910087+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ANIP DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1023024/000102302426000039/anip-20260408.htm","published_at":"2026-04-09T00:00:00+00:00","last_checked_at":"2026-05-15T21:06:10.840889+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":["Compensation","Governance/Nominating"],"claim_text":"Renee P. Tannenbaum, Pharm.D. serves on Compensation, Governance/Nominating.","claim_state":"verified","valid_from":"2026-04-23","valid_to":null,"confidence":0.88,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T23:01:35.810918+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"CRDF DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1213037/000121303726000006/crdf-20260423.htm","published_at":"2026-04-23T00:00:00+00:00","last_checked_at":"2026-05-15T23:01:35.718861+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":["Compensation","Nominating/Governance"],"claim_text":"Renee P. Tannenbaum, Pharm.D. serves on Compensation, Nominating/Governance.","claim_state":"verified","valid_from":"2026-04-09","valid_to":null,"confidence":0.88,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T21:06:10.933028+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ANIP DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1023024/000102302426000039/anip-20260408.htm","published_at":"2026-04-09T00:00:00+00:00","last_checked_at":"2026-05-15T21:06:10.840889+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_company","claim_value":"Bench International","claim_text":"Renee P. Tannenbaum, Pharm.D. is linked to Bench International as an operating executive.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T21:06:11.056826+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ANIP DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1023024/000102302426000039/anip-20260408.htm","published_at":"2026-04-09T00:00:00+00:00","last_checked_at":"2026-05-15T21:06:10.840889+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_role","claim_value":"Corporate Development Advisor","claim_text":"Renee P. Tannenbaum, Pharm.D. is also listed as Corporate Development Advisor.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T21:06:11.039465+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ANIP DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1023024/000102302426000039/anip-20260408.htm","published_at":"2026-04-09T00:00:00+00:00","last_checked_at":"2026-05-15T21:06:10.840889+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Proxy extraction classified cybersecurity experience for Renee P. Tannenbaum, Pharm.D. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T23:01:35.864529+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"CRDF DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1213037/000121303726000006/crdf-20260423.htm","published_at":"2026-04-23T00:00:00+00:00","last_checked_at":"2026-05-15T23:01:35.718861+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":false,"claim_text":"Proxy extraction classified technology background for Renee P. Tannenbaum, Pharm.D. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T23:01:35.846574+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"CRDF DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1213037/000121303726000006/crdf-20260423.htm","published_at":"2026-04-23T00:00:00+00:00","last_checked_at":"2026-05-15T23:01:35.718861+00:00","relation":"supports","excerpt_locator":null}]},{"subject":"alpha:person:renee-p-tannenbaum-pharm-d","claim_type":"board_service","claim_value":{"tags":[],"title":"Director","period":"2022-01-01 · current","organization":"ANI PHARMACEUTICALS INC","organization_id":"ani-pharmaceuticals-inc"},"claim_text":"Director at ANI PHARMACEUTICALS INC (2022-01-01 · current)","valid_from":null,"valid_to":null,"verification_status":"confirmed","date_precision":"period_text_only","evidence":[{"source_url":"https://www.sec.gov/Archives/edgar/data/1023024/000102302426000039/anip-20260408.htm","label":"sec_proxy","evidence_state":"verified"}],"claim_state":"confirmed","version":1},{"subject":"alpha:person:renee-p-tannenbaum-pharm-d","claim_type":"board_service","claim_value":{"tags":[],"title":"Director","period":"2021-01-01 · current","organization":"Cardiff Oncology, Inc.","organization_id":"cardiff-oncology-inc"},"claim_text":"Director at Cardiff Oncology, Inc. (2021-01-01 · current)","valid_from":null,"valid_to":null,"verification_status":"confirmed","date_precision":"period_text_only","evidence":[{"source_url":"https://www.sec.gov/Archives/edgar/data/1213037/000121303726000006/crdf-20260423.htm","label":"sec_proxy","evidence_state":"verified"}],"claim_state":"confirmed","version":1}],"network":{"schema_version":"alpha-profile-network-public-v1","relationships":[],"relationship_pathfinding":false,"authentication_prompt":"Sign in to see how you're connected.","limitations":["Representative factual associations only.","Shared contexts do not assert personal acquaintance.","Anonymous graph traversal is not available."]},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only permissioned public claims and evidence are included.","Absence of a claim is not evidence that the underlying fact is false.","Public retrieval does not grant model-training or redistribution rights.","Private relationships and Council activity are excluded."],"structured_data":{"@context":"https://schema.org","@type":"ProfilePage","@id":"https://registry.alpha.ac/people/renee-p-tannenbaum-pharm-d#profile","url":"https://registry.alpha.ac/people/renee-p-tannenbaum-pharm-d","dateModified":"2026-05-15T23:01:35.659+00:00","mainEntity":{"@type":"Person","@id":"https://registry.alpha.ac/people/renee-p-tannenbaum-pharm-d#person","name":"Renee P. Tannenbaum, Pharm.D.","url":"https://registry.alpha.ac/people/renee-p-tannenbaum-pharm-d","jobTitle":"Director","worksFor":{"@type":"Organization","name":"ANI PHARMACEUTICALS INC","tickerSymbol":"NASDAQ: ANIP"},"affiliation":[{"@type":"OrganizationRole","roleName":"Director","startDate":"2022-01-01","memberOf":{"@type":"Organization","name":"ANI PHARMACEUTICALS INC","url":"https://registry.alpha.ac/companies/ani-pharmaceuticals-inc","tickerSymbol":"NASDAQ: ANIP"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2021-01-01","memberOf":{"@type":"Organization","name":"Cardiff Oncology, Inc.","url":"https://registry.alpha.ac/companies/cardiff-oncology-inc","tickerSymbol":"NASDAQ: CRDF"}}]},"isBasedOn":[{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1213037/000121303726000006/crdf-20260423.htm","name":"CRDF DEF 14A director slate"},{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1023024/000102302426000039/anip-20260408.htm","name":"ANIP DEF 14A director slate"}],"mainEntityOfPage":"https://registry.alpha.ac/people/renee-p-tannenbaum-pharm-d"},"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"corroborated","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":11,"corroborated":1,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"At least one published claim is corroborated by two or more public sources. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":12,"under_review_claim_count":0,"owner_supplied_claim_count":0,"evidence_record_count":6,"distinct_source_count":2,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"corroborated","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":11,"corroborated":1,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"At least one published claim is corroborated by two or more public sources. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":12,"corroborated_claims":1,"sources":6,"distinct_sources":2,"role_claims":2,"last_reviewed_at":"2026-05-15T23:01:35.659+00:00","observed_at":"2026-09-22T01:53:10.007546+00:00","freshness_days":129}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"person","slug":"renee-p-tannenbaum-pharm-d","canonical_url":"https://registry.alpha.ac/people/renee-p-tannenbaum-pharm-d"},"publication":{"published_at":"2026-09-02T02:37:22.434232+00:00","last_reviewed_at":"2026-05-15T23:01:35.659+00:00","as_of":"2026-09-22T01:53:10.007546+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/people/renee-p-tannenbaum-pharm-d","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/profiles/renee-p-tannenbaum-pharm-d","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/people/renee-p-tannenbaum-pharm-d.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}}}